Skip to main content

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Publication ,  Journal Article
Shavers, VL; Brown, M; Klabunde, CN; Potosky, AL; Davis, W; Moul, J; Fahey, A
Published in: Med Care
March 2004

BACKGROUND: Previous studies have found that racial/ethnic minority patients with prostate cancer are more frequently managed with "watchful waiting." Little, however, is known about the medical care received among men managed with watchful waiting. We examine the type and intensity of medical monitoring received by African American, Hispanic, and white patients with prostate cancer managed with "watchful waiting" in fee-for-service systems. METHODS: Surveillance Epidemiology and End Results-Medicare data for men diagnosed with prostate cancer 1994-1996 were used in this study. Men were determined to have initially received watchful waiting if they did not receive surgery, radiation, or hormone treatment within the first 7 months of diagnosis. Crosstabulations, multivariate logistic, and Cox regressions were used to examine the association between clinical and sociodemographic variables and the receipt of a primary care, urology visit, prostate-specific antigen test, or bone scan. RESULTS: In general, Hispanic and African American men received less medical monitoring and had longer median times from diagnosis to receipt of a medical monitoring visit or procedure than white men. Furthermore, nearly 6% of African American, 5% of Hispanic, and 1% of white men did not have any medical monitoring visits or procedures during the 60-month follow-up period (P<0.001). Differences in observed clinical or sociodemographic characteristics did not explain variations in medical monitoring. CONCLUSION: Regular medical monitoring is considered by most medical authorities to be a necessary component of management with watchful waiting. The disproportionately low receipt of medical monitoring visits and procedures observed for African American and Hispanic men managed with watchful waiting in this study suggest that there are racial/ethnic disparities in the receipt of appropriate prostate cancer management.

Duke Scholars

Published In

Med Care

DOI

ISSN

0025-7079

Publication Date

March 2004

Volume

42

Issue

3

Start / End Page

239 / 250

Location

United States

Related Subject Headings

  • White People
  • United States
  • Time Factors
  • Socioeconomic Factors
  • SEER Program
  • Registries
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Proportional Hazards Models
  • Practice Patterns, Physicians'
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shavers, V. L., Brown, M., Klabunde, C. N., Potosky, A. L., Davis, W., Moul, J., & Fahey, A. (2004). Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care, 42(3), 239–250. https://doi.org/10.1097/01.mlr.0000117361.61444.71
Shavers, Vickie L., Martin Brown, Carrie N. Klabunde, Arnold L. Potosky, William Davis, Judd Moul, and Angela Fahey. “Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.Med Care 42, no. 3 (March 2004): 239–50. https://doi.org/10.1097/01.mlr.0000117361.61444.71.
Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, et al. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care. 2004 Mar;42(3):239–50.
Shavers, Vickie L., et al. “Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.Med Care, vol. 42, no. 3, Mar. 2004, pp. 239–50. Pubmed, doi:10.1097/01.mlr.0000117361.61444.71.
Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care. 2004 Mar;42(3):239–250.

Published In

Med Care

DOI

ISSN

0025-7079

Publication Date

March 2004

Volume

42

Issue

3

Start / End Page

239 / 250

Location

United States

Related Subject Headings

  • White People
  • United States
  • Time Factors
  • Socioeconomic Factors
  • SEER Program
  • Registries
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Proportional Hazards Models
  • Practice Patterns, Physicians'